- $155.61bn
- $204.48bn
- $63.63bn
- 98
- 84
- 91
- 100
Pfizer Inc - EyeCyte, Inc. Secures Series A Funding from Pfizer
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of June 4 Pfize
AnnouncementPfizer Inc - Pfizers Growing Strength in Oncology
AnnouncementPfizer Inc - New Pfizer Oncology Data Across Numerous Cancer Types to be Present
AnnouncementPfizer Inc - Pfizer Announces Discontinuation of Phase III Clinical Trial for Pa
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of Pfizer Parti
AnnouncementPfizer Inc - Pfizer Will Immediately Seek to Appeal Lipitor Patent Ruling in Nor
AnnouncementPfizer Inc - New Vice President
AnnouncementPfizer Inc - Pfizer Names Sally Susman Senior Vice President of Worldwide Commun
AnnouncementPfizer Inc - Regulatory Approval
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of April 17 Con
AnnouncementPfizer Inc - Norvasc Patent
AnnouncementPfizer Inc Pfizer Plans to Reconfigure Global Plant Network
AnnouncementPfizer Inc - Pfizer Successfully Completes Tender Offer for Shares of Encysive P
AnnouncementPfizer Inc - Regulatory Approval
AnnouncementPfizer Inc - Long-Term Data Reinforce Safety and Efficacy Profile of Pfizers Ne
AnnouncementPfizer Inc - Pfizer Discontinues Development Program for Its Phase 3 Obesity Com
AnnouncementPfizer Inc - Sutent Significantly Increases Progression Free Survival for Patien
AnnouncementPfizer Inc Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In No
Announcement